NASDAQ: TENX
Tenax Therapeutics Inc Stock Ownership - Who owns Tenax Therapeutics?

Insider buying vs selling

Have Tenax Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Stuart RichChief Medical Officer2025-12-092,500$10.22
$25.54kBuy
Stuart RichChief Medical Officer2025-12-082,500$10.10
$25.25kBuy
Stuart RichChief Medical Officer2025-12-042,500$9.20
$23.00kBuy
Stuart RichChief Medical Officer2025-12-031,500$9.08
$13.62kBuy
Stuart RichChief Medical Officer2025-12-021,000$9.01
$9.01kBuy
Christopher Thomas GiordanoCEO2025-11-20538$7.59
$4.08kBuy
Christopher Thomas GiordanoCEO2025-11-19455$7.51
$3.42kBuy
June Sherie AlmenoffDirector2025-11-181,900$7.52
$14.28kBuy
June Sherie AlmenoffDirector2025-11-181,900$7.52
$14.28kBuy
June Sherie AlmenoffDirector2025-11-181,900$7.52
$14.28kBuy

1 of 2

TENX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TENX insiders and whales buy or sell their stock.

TENX Shareholders

What type of owners hold Tenax Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC22.73%6,027,985$69.20MInsider
Price T Rowe Associates Inc11.13%2,951,116$33.88MInstitution
Janus Henderson Group PLC6.84%1,815,474$20.84MInstitution
Venrock Adviser LLC6.32%1,675,262$19.23MInstitution
Perceptive Advisors LLC5.46%1,447,782$16.62MInstitution
John P. Kelley4.84%1,282,932$14.73MInsider
Ikarian Capital LLC3.84%1,017,600$11.68MInstitution
Stonepine Capital Management LLC3.68%975,200$11.20MInstitution
Logos Global Management LP2.36%625,000$7.18MInstitution
Morgan Stanley2.25%596,564$6.85MInstitution

1 of 3

TENX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TENX72.85%27.15%Net Buying
DMAC21.71%69.04%Net Buying
RCKT50.53%49.47%Net SellingNet Selling
PALI84.51%6.58%Net Buying
FENC4.51%95.49%Net SellingNet Buying

Tenax Therapeutics Stock Ownership FAQ

Who owns Tenax Therapeutics?

Tenax Therapeutics (NASDAQ: TENX) is owned by 81.02% institutional shareholders, 30.19% Tenax Therapeutics insiders, and 0.00% retail investors. Armistice Capital LLC is the largest individual Tenax Therapeutics shareholder, owning 6.03M shares representing 22.73% of the company. Armistice Capital LLC's Tenax Therapeutics shares are currently valued at $69.20M.

If you're new to stock investing, here's how to buy Tenax Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.